Your signal. Your price.
Google’s drug-discovery spinoff Isomorphic Labs is reportedly raising $5 billion at a $50 billion valuation to expand its operations. The company builds on DeepMind’s AlphaFold work, and Demis Hassabis shifted to chairman partly to focus on scaling it.
Only 1 result for these filters — try broadening your search